Brian's Big Idea: Healthcare Stocks

Zacks01-30

One of the most difficult sectors to invest in is the healthcare sector. Not only do you have to be nuanced in the ways of the stock market but you also have to have a deep understanding of medicines,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2507566281?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-30 05:12","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2507566281","market":"us","top_or_hot":-1,"title":"Brian's Big Idea: Healthcare Stocks","media":"Zacks","content":"<div>\n<p>One of the most difficult sectors to invest in is the healthcare sector. Not only do you have to be nuanced in the ways of the stock market but you also have to have a deep understanding of medicines,...</p>\n\n<a href=\"https://finance.yahoo.com/news/brians-big-idea-healthcare-stocks-211200968.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Brian's Big Idea: Healthcare Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBrian's Big Idea: Healthcare Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-30 05:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/brians-big-idea-healthcare-stocks-211200968.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the most difficult sectors to invest in is the healthcare sector. Not only do you have to be nuanced in the ways of the stock market but you also have to have a deep understanding of medicines,...</p>\n\n<a href=\"https://finance.yahoo.com/news/brians-big-idea-healthcare-stocks-211200968.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4137","symbol_name":"综合支持服务","start_time":0,"source_url":"https://finance.yahoo.com/news/brians-big-idea-healthcare-stocks-211200968.html","article_id":"2507566281","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2507566281","pubTimestamp":1738185120,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"One of the most difficult sectors to invest in is the healthcare sector. Not only do you have to be nuanced in the ways of the stock market but you also have to have a deep understanding of medicines, machines, and biology in general.Whether you were looking at medical instruments and devices or biotechnology stocks the goal is always the same thing. Investors are looking for what will work today and tomorrow and how to be best positioned for down the road.One stock that is getting a lot of attention is Hims & Hers HIMS. This company delivers medicine discreetly to your door but has been running hard ever since it started including GLP1 weight loss drugs. Savvy investors know that there is a shortage of GLP which allows HIMS to be in this space, but it won’t last forever. There is a significant short interest position on the stock, but that hasn’t slowed investors from gobbling up shares.BridgeBio Pharma, Inc.  : Free Stock Analysis Report. Hims & Hers Health, Inc.  : Free Stock Analys","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4137":"综合支持服务","BK4139":"生物科技","BK4505":"高瓴资本持仓","BK4588":"碎股","BBIO":"BridgeBio Pharma, Inc.","HIMS":"Hims & Hers Health Inc.","VCYT":"Veracyte Inc","BK4196":"保健护理服务","HCSG":"医疗保健服务","BK4585":"ETF&股票定投概念"},"translate_title":"布莱恩的伟大想法：医疗保健股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BBIO":1,"HCSG":1,"HIMS":1,"VCYT":0.9},"content_text":"One of the most difficult sectors to invest in is the healthcare sector. Not only do you have to be nuanced in the ways of the stock market but you also have to have a deep understanding of medicines, machines, and biology in general.\nWhether you were looking at medical instruments and devices or biotechnology stocks the goal is always the same thing. Investors are looking for what will work today and tomorrow and how to be best positioned for down the road.\nOne stock that is getting a lot of attention is Hims & Hers HIMS. This company delivers medicine discreetly to your door but has been running hard ever since it started including GLP1 weight loss drugs. Savvy investors know that there is a shortage of GLP which allows HIMS to be in this space, but it won’t last forever. There is a significant short interest position on the stock, but that hasn’t slowed investors from gobbling up shares.\nIn the video attached to this article we take a look at HIMS.\nAnother aspect that must be understood is medical devices. Veracyte VCYT is a Zacks Rank #1 (Strong Buy) that has Zacks Style Scores that will attract growth investors. The Zacks Style Score for value is an F while the Zacks Style Score for Growth is an A. I like to say that when I see that type of divergence in the style scores I know I am on the right path as an aggressive growth investor.\nVeracyte VCYT is profiled in the video that is related to this article.\nDrugs that pass the rigorous testing of Phase I, Phase II and Phase III become commercialized and many go on to post enormous profits. At some time, however, the FDA allows for a generic equivalent to be produced and sold. BridgeBio Pharma BBIO is a company that does just that. The stock is currently a Zacks Rank #2 (Strong Buy) and with inflation eating away at consumers wallets, the likelihood of switching to a generic (when available) is very strong.\nNow all of this is very complex and can be overwhelming for regular investors. To solve this problem Zacks has a service called Healthcare Innovators and is run by Kevin Cook.\nKevin is an accomplished trader and he has embraced the healthcare sector like few others. He has obtained a deep understanding of biotechnology companies as well as medical device manufacturers and even the insurance providers in the space.\nWhen we combine an accomplished trader with a thorough understanding of the healthcare sector we have a very powerful tool. Kevin leverages the Zacks Rank to help him make trades and long term investments in the best healthcare stocks.\nBe sure to check out Healthcare Innovators at www.Zacks.com.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nVeracyte, Inc. (VCYT) : Free Stock Analysis Report\nBridgeBio Pharma, Inc. (BBIO) : Free Stock Analysis Report\nHims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2507566281"}